• Own full lifecycle delivery from kickoff through go-live and stabilization—across all platform components (RCM, patient engagement, clinician workflow tools, VBC MSO services) • Translate contractual scope into a sequenced, executable implementation roadmap with clear milestones, dependencies, and critical paths • Drive integration of multiple products into a unified operational workflow, not siloed deployments • Build and actively manage detailed project plans, RAID logs (risks, assumptions, issues, dependencies), and weekly execution dashboards • Enforce timeline discipline and accountability across internal teams (product, engineering, ops) and external client stakeholders • Identify risks early and intervene decisively to unblock execution—this is a “fix it before it escalates” role • Serve as the central point of coordination across internal teams: product, engineering, data integration, operations, client success • Ensure alignment on data integrations (EHR, PM systems), workflow redesign, and operational readiness • Engage directly with executive sponsors (internal & client-side) to provide transparent progress updates; escalate and resolve critical risks; drive decision-making to maintain momentum

Role Description We are seeking a Vice President & Clinical Executive Consultant (CEC) to join our Strategic Consulting Team, whose mission is to deliver quantitative thought leadership across design, statistical methods, and decision-making during therapeutic product development. - Expand Cytel’s reputation for innovation and thought leadership by guiding strategic engagements for pharmaceutical, biotech, and medical device clients. - Build and maintain enduring client relationships in collaboration with Cytel’s business development teams and cross-functional colleagues. - Develop and demonstrate expertise in clinical trial design, statistical methodology, and strategic clinical development planning. - Ensure Cytel remains at the forefront of industry innovation and enhance visibility and recognition across the global clinical development landscape. - Design and execute Phase I–IV clinical trials for novel therapeutics. - Provide strategic consulting on clinical, safety/pharmacovigilance, regulatory, and market access pathways to accelerate patient access to new health technologies. Qualifications - Deep and broad experience in designing and executing Phase I–IV clinical trials. - Expertise in related quantitative domains such as adaptive designs, clinical pharmacology, data science, or model-informed drug development. Company Description

• Lead a modern data privacy program across AI infrastructure, cloud and SaaS platforms • Design, implement, and evolve a scalable global data privacy framework based on ISO 27701 and other international standards. • Serve as the subject matter expert on current and emerging global and regional privacy regulations such as GDPR, CCPA/CPRA, LGPD, DPDP, PDPA, and APPI. • Oversee and maintain certification and compliance with the EU-US Data Privacy Framework (DPF). • Conduct and oversee Data Protection Impact Assessments (DPIAs) for new and existing high-risk products, vendors, and internal processes. • Collaborate with Engineering, Product and other cross-functional teams to ensure that privacy controls are appropriately incorporated into the Product or other business applications. • Lead the privacy component of external audits (SOC2, ISO) and represent Saviynt’s privacy posture during customer-facing due diligence and security reviews. • Partner with the Legal team to draft, review, and negotiate Data Processing Agreements (DPAs) and privacy related clauses in vendor and customer contracts. • Evaluate the privacy practices of third-party processors to ensure they meet Saviynt’s data protection requirements. • Participate in Incident Response efforts and Team and drive privacy related impact assessments, and other related response actions. • Ability to translate complex regulations and legal mandates into clear, actionable guidance for product managers and engineers to consume. • Establish and operate a Privacy Incident Reporting and Response process to address any Privacy incidents that might occur in various geographic regions. • Oversee the end-to-end process for Data Subject Access Requests (DSARs) and the "Right to be Forgotten" across all jurisdictions. • Build and deliver high-impact privacy awareness programs tailored to different departments.

• Establish the EU North operating entity from inception, including recruitment of the core leadership team, legal and infrastructure set-up, and governance in coordination with International HQ • Lead launch planning and execution for infigratinib, encaleret, and subsequent pipeline assets across the Nordic markets, with appropriate sequencing and investment pacing by country • Lead BridgeBio's market access engagement, evidence strategy, and organizational readiness in the United Kingdom and Ireland; drive the strategic judgement on when and how to transition to active launch for each asset. • Own the cluster P&L end-to-end — forecasting, investment prioritization, risk management, and performance delivery across launch, pre-launch, and in-line periods. • Develop and execute reimbursement and pricing strategies tailored to each national authority in the cluster, including early scientific advice, evidence planning, managed-entry agreements, and risk-sharing frameworks • Build and sustain durable relationships with the leading cardiologists, endocrinologists, and skeletal dysplasia specialists across the cluster. Ensure BridgeBio is recognized as the scientific and clinical partner of choice in ATTR-CM, achondroplasia, and ADH1/chronic hypoparathyroidism. In rare disease, this is not an activity to delegate — the General Manager will be personally active in this engagement as a senior, credible, and mission-led presence • Establish BridgeBio as a trusted, long-term partner to rare disease patient organizations across the cluster, spanning the ATTR amyloidosis, achondroplasia, and hypoparathyroidism and ADH1 communities. Recognize that in rare disease, the patient voice is central to access, to policy influence, and to the credibility with which we operate — and lead accordingly • Partner closely with Medical Affairs, Regulatory, Market Access, Finance, Legal, Compliance, and Commercial Operations at International HQ to deliver an integrated launch and pre-launch construct across all three geographies • Represent BridgeBio externally with integrity, including engagement with national industry associations, compliance frameworks, and broader EU and national policy fora • Anticipate macroeconomic, political, regulatory, and competitive trends affecting the region and translate them into action for the business • Reinforce BridgeBio's core values in every hire, every partnership, and every interaction